Schwann Cells
Overview
Schwann cells are glial cells derived from neural crest cells that form the myelin sheaths surrounding axons in the peripheral nervous system (PNS). Unlike oligodendrocytes in the central nervous system (CNS), which can myelinate multiple axon segments, each Schwann cell myelinates a single internode (segment between nodes of Ranvier) of one axon. In addition to myelinating Schwann cells, non-myelinating Schwann cells exist that ensheath multiple small-diameter unmyelinated axons without forming myelin wrappings. Schwann cells are essential for axonal maintenance, metabolic support, and nerve regeneration throughout the lifespan.
Function/Biology
Schwann cells perform multiple critical functions beyond myelination. They synthesize and maintain myelin, the lipid-rich insulating sheath that enables rapid saltatory conduction of action potentials along axons. This myelin consists of multiple concentric layers of the Schwann cell plasma membrane wrapped around the axon, with the myelin basic protein (MBP) and proteolipid protein (PLP) serving as major structural components.
Non-myelinating Schwann cells provide trophic support to unmyelinated nerve fibers and sensory neurons. These cells secrete neurotrophic factors including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF), which promote axonal survival and growth. Schwann cells also contribute to the blood-nerve barrier through tight junctions and express various adhesion molecules that maintain axon-glial interactions.
...Schwann Cells
Overview
Schwann cells are glial cells derived from neural crest cells that form the myelin sheaths surrounding axons in the peripheral nervous system (PNS). Unlike oligodendrocytes in the central nervous system (CNS), which can myelinate multiple axon segments, each Schwann cell myelinates a single internode (segment between nodes of Ranvier) of one axon. In addition to myelinating Schwann cells, non-myelinating Schwann cells exist that ensheath multiple small-diameter unmyelinated axons without forming myelin wrappings. Schwann cells are essential for axonal maintenance, metabolic support, and nerve regeneration throughout the lifespan.
Function/Biology
Schwann cells perform multiple critical functions beyond myelination. They synthesize and maintain myelin, the lipid-rich insulating sheath that enables rapid saltatory conduction of action potentials along axons. This myelin consists of multiple concentric layers of the Schwann cell plasma membrane wrapped around the axon, with the myelin basic protein (MBP) and proteolipid protein (PLP) serving as major structural components.
Non-myelinating Schwann cells provide trophic support to unmyelinated nerve fibers and sensory neurons. These cells secrete neurotrophic factors including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF), which promote axonal survival and growth. Schwann cells also contribute to the blood-nerve barrier through tight junctions and express various adhesion molecules that maintain axon-glial interactions.
During peripheral nerve injury, Schwann cells undergo morphological and molecular changes that facilitate the clearance of axonal debris and create a permissive environment for regeneration. This process, termed denervation, involves activation of c-Jun and other transcription factors that upregulate regeneration-associated genes.
Role in Neurodegeneration
Schwann cell dysfunction contributes to multiple neurodegenerative conditions affecting the PNS. In Charcot-Marie-Tooth (CMT) disease, mutations in myelin-related genes such as PMP22 (peripheral myelin protein 22), MFN2 (mitofusin 2), and GJB1 (connexin 32) cause progressive peripheral nerve degeneration. PMP22 mutations particularly lead to myelin instability and secondary axonal loss.
In diabetic peripheral neuropathy, chronic hyperglycemia impairs Schwann cell metabolism and reduces trophic factor production, compromising axonal support and promoting neurodegeneration. Similarly, in amyloid lateral sclerosis (ALS), Schwann cells show reduced GDNF and NGF expression, contributing to motor neuron degeneration in the PNS.
Schwann cells also participate in the pathology of demyelinating diseases like Guillain-Barré syndrome (GBS), where autoimmune responses target myelin antigens. Additionally, toxic exposures affecting Schwann cells can precipitate neuropathies, emphasizing their vulnerability in neurodegenerative processes.
Molecular Mechanisms
Schwann cell biology is regulated by multiple signaling pathways. The neuregulin-1 (NRG1)/ErbB receptor pathway controls Schwann cell proliferation, survival, and myelination. NRG1 secreted by neurons activates ErbB2/ErbB3 heterodimers on Schwann cells, triggering downstream PI3K/Akt and MEK/ERK signaling cascades essential for myelin formation and maintenance.
Calcium signaling in Schwann cells involves IP3 receptors and ryanodine receptors, regulating gene expression and metabolic activity. Autophagy maintains Schwann cell homeostasis through selective degradation of damaged organelles and proteins, with impaired autophagy contributing to myelin pathology in some degenerative conditions.
Schwann cells express tight junction proteins including claudins, occludin, and ZO-1 that establish the blood-nerve barrier. Gap junctions composed of connexin-32 enable intercellular communication between Schwann cells and between Schwann cells and axons.
Clinical/Research Significance
Understanding Schwann cell biology has significant therapeutic implications. Regenerative approaches promoting Schwann cell activity and myelin repair show promise for treating peripheral neuropathies. Cell transplantation strategies utilizing engineered Schwann cells are being investigated for PNS repair after traumatic injury and in genetic demyelinating diseases.
Biomarkers reflecting Schwann cell integrity and function—such as myelin protein levels in peripheral blood or cerebrospinal fluid—could improve diagnosis and monitoring of peripheral neurodegenerative conditions. Pharmacological interventions targeting NRG1/ErbB signaling or promoting trophic factor expression represent potential disease-modifying therapies.
- Myelin and myelination
- Oligodendrocytes
- Peripheral nervous system
- Nodes of Ranvier
- Charcot-Marie-Tooth disease
- Diabetic neuropathy
- Neuregulin signaling
- GDNF and neurotrophic factors
- Blood-nerve barrier
-